Cargando…
Comment on Hochfellner et al. Accuracy Assessment of the GlucoMen(®) Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study. Biosensors 2022, 12, 106
Autores principales: | Freckmann, Guido, Eichenlaub, Manuel, Waldenmaier, Delia, Pleus, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376955/ https://www.ncbi.nlm.nih.gov/pubmed/37504108 http://dx.doi.org/10.3390/bios13070709 |
Ejemplares similares
-
Reply to Freckmann et al. Comment on “Hochfellner et al. Accuracy Assessment of the GlucoMen(®) Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study. Biosensors 2022, 12, 106”
por: Hochfellner, Daniel A., et al.
Publicado: (2023) -
Accuracy Assessment of the GlucoMen(®) Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study
por: Hochfellner, Daniel A., et al.
Publicado: (2022) -
Evaluation of Accuracy and Performance of isCGM Sensors during Experimentally Induced Glucose Excursions. Comment on Moser et al. Performance of the Intermittently Scanned Continuous Glucose Monitoring (isCGM) System during a High Oral Glucose Challenge in Adults with Type 1 Diabetes—A Prospective Secondary Outcome Analysis. Biosensors 2021, 11, 22
por: Jessen, Wiebke, et al.
Publicado: (2022) -
First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy
por: Waldenmaier, Delia, et al.
Publicado: (2018) -
Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study
por: Waldenmaier, Delia, et al.
Publicado: (2021)